• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喉癌和下咽癌之间的进展差异并非由肿瘤大小和血管形成所致。

Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.

作者信息

Lukits J, Timár J, Juhász A, Döme B, Paku S, Répássy G

机构信息

1st Institute of Pathology and Experimental Cancer Research, Budapest, Hungary.

出版信息

Otolaryngol Head Neck Surg. 2001 Jul;125(1):18-22. doi: 10.1067/mhn.2001.116187.

DOI:10.1067/mhn.2001.116187
PMID:11458208
Abstract

A recent survey of head and neck cancer indicated a sharp difference in survival between cancer of the hypopharynx and cancers formed in other head and neck sites. We have analyzed tumor size relative to clinical stage and vascularization as possible causes for such a difference in a series of 21 patients with cancer of the laryngopharynx (11 glottic and 10 hypopharyngeal). We found that the volume of the smallest cancers of the larynx at stage 2 is significantly larger than the volume of the cancers of the hypopharynx at stage 4 (P < 0.05). Next, we have determined by immunohistochemistry and morphometry the microvessel density, microvessel perimeter, and vascular endothelial growth factor (VEGF) expression of laryngo-hypopharyngeal cancers. Analysis of these data indicates that there is no difference in vascularization and VEGF expression between these two tumor types. These data strongly suggest that the invasive but not the angiogenic phenotype of hypopharyngeal cancer cells could be responsible for the more aggressive biologic behavior of this head and neck cancer subtype.

摘要

最近一项关于头颈癌的调查表明,下咽癌与其他头颈部位形成的癌症在生存率上存在显著差异。我们分析了21例喉咽癌患者(11例声门癌和10例下咽癌)的肿瘤大小与临床分期及血管形成情况,以此作为造成这种差异的可能原因。我们发现,2期喉癌最小肿瘤的体积显著大于4期下咽癌肿瘤的体积(P < 0.05)。接下来,我们通过免疫组织化学和形态学测定了喉咽癌的微血管密度、微血管周长和血管内皮生长因子(VEGF)表达。对这些数据的分析表明,这两种肿瘤类型在血管形成和VEGF表达方面没有差异。这些数据有力地表明,下咽癌细胞的侵袭性而非血管生成表型可能是导致这种头颈癌亚型具有更强侵袭性生物学行为的原因。

相似文献

1
Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.喉癌和下咽癌之间的进展差异并非由肿瘤大小和血管形成所致。
Otolaryngol Head Neck Surg. 2001 Jul;125(1):18-22. doi: 10.1067/mhn.2001.116187.
2
[Characterization of laryngopharyngeal tumors. Tumor size and vascularization].[喉咽肿瘤的特征。肿瘤大小与血管形成]
Magy Onkol. 2000 Oct 1;44(3):239-245.
3
[The effect of the microenvironment of head and neck cancers on tumor progression].[头颈部癌症的微环境对肿瘤进展的影响]
Magy Onkol. 2009 Mar;53(1):51-9. doi: 10.1556/MOnkol.53.2009.1.8.
4
Angiogenesis and the expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa.梨状窝鳞状细胞癌中血管生成及血管内皮生长因子A和C的表达
Arch Otolaryngol Head Neck Surg. 2003 Oct;129(10):1110-4. doi: 10.1001/archotol.129.10.1110.
5
[Therapy and prognosis in 360 laryngeal and hypopharyngeal cancers at the Erfurt ENT clinic 1978-1987].[1978 - 1987年爱尔福特耳鼻喉科诊所360例喉癌和下咽癌的治疗与预后]
HNO. 1990 Apr;38(4):125-8.
6
Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.缺氧相关标志物在晚期喉癌和下咽鳞状细胞癌中的预后价值
Laryngoscope. 2015 Jan;125(1):E8-15. doi: 10.1002/lary.24933. Epub 2014 Sep 17.
7
Radiotherapy alone for early-stage squamous cell carcinoma of the larynx and hypopharynx.早期喉和下咽鳞状细胞癌的单纯放射治疗
Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S31-6. doi: 10.1016/j.ijrobp.2007.04.092.
8
Perineural invasion of the major and minor nerves in laryngeal and hypopharyngeal cancer.喉癌和下咽癌中主要及次要神经的神经周围浸润
Otolaryngol Head Neck Surg. 2009 Jan;140(1):65-9. doi: 10.1016/j.otohns.2008.10.019.
9
Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.血管内皮生长因子的强免疫组化表达可预测头颈部鳞状细胞癌的总生存期。
Ann Surg Oncol. 2007 Dec;14(12):3558-65. doi: 10.1245/s10434-007-9632-0. Epub 2007 Oct 11.
10
[Contralateral metastasis in patients with cancer of the larynx and the hypopharynx. Analysis and critical review of our caseload].[喉癌和下咽癌患者的对侧转移。对我们病例数量的分析与批判性回顾]
Acta Otorhinolaryngol Ital. 1990 Jan-Feb;10(1):11-8.

引用本文的文献

1
Biomarker Profiles and Clinicopathological Features in Head and Neck Squamous Cell Carcinoma Patients.头颈部鳞状细胞癌患者的生物标志物谱和临床病理特征。
Medicina (Kaunas). 2024 Oct 14;60(10):1681. doi: 10.3390/medicina60101681.
2
Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.下咽及喉鳞状细胞癌的蛋白质组学分析揭示了生存率的差异。
Sci Rep. 2020 Nov 10;10(1):19459. doi: 10.1038/s41598-020-76626-w.
3
Expression of hypoxic signaling markers in head and neck squamous cell carcinoma and its clinical significance.
缺氧信号标志物在头颈部鳞状细胞癌中的表达及其临床意义。
Eur Arch Otorhinolaryngol. 2015 Jan;272(1):219-28. doi: 10.1007/s00405-014-2954-1. Epub 2014 Mar 14.
4
The role of tumor size and patient's age as prognostic factors in laryngeal cancer.肿瘤大小和患者年龄作为喉癌预后因素的作用。
Hippokratia. 2011 Jan;15(1):75-80.
5
Differential biomarker expression in head and neck cancer correlates with anatomical localization.头颈部癌症中差异生物标志物的表达与解剖定位相关。
Pathol Oncol Res. 2011 Sep;17(3):721-7. doi: 10.1007/s12253-011-9376-9. Epub 2011 Apr 13.
6
Does primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site outcome?在头颈部鳞状细胞癌的确定性同期放化疗过程中早期进行的原发肿瘤体积测量是否能改善原发部位结局的预测?
Br J Radiol. 2010 Nov;83(995):964-70. doi: 10.1259/bjr/27631720.
7
Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites.运用组合蛋白质组学分析来证明源自不同亚部位的头颈部鳞状细胞癌的分子相似性。
Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):694-703. doi: 10.1001/archoto.2009.78.
8
Size, shape, structure, and direction of angiogenesis in laryngeal tumour development.喉肿瘤发展过程中血管生成的大小、形状、结构及方向
J Clin Pathol. 2004 Apr;57(4):394-401. doi: 10.1136/jcp.2002.004978.